News Conference News ESC 2025 Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF Michael O'Riordan August 30, 2025
News Conference News ACC 2024 Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI Michael O'Riordan April 07, 2024
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News TCT 2021 Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes Yael L. Maxwell November 09, 2021
News Conference News TCT 2021 FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021
News Conference News ESC 2020 New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials Caitlin E. Cox September 03, 2020
News Conference News AHA 2019 EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl Todd Neale November 18, 2019
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News CRT 2017 Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy Michael O'Riordan February 20, 2017
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
News Conference News ACC 2016 EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI Caitlin E. Cox April 03, 2016
News Conference News TCT 2013 Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias November 04, 2013
News Conference News AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab November 13, 2011